Schonfeld Strategic Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-376,583	Closed	-$19.5M	–	3377
2022 Q3	$19.5M	Buy	376,583 +329,252	+696%	+$13.6M	0.16%	175
2022 Q2	$1.17M	Buy	+47,331	New	+$1.04M	0.01%	947
2022 Q1	–	Sell	-7,500	Closed	-$273K	–	3102
2021 Q4	$273K	Buy	+7,500	New	+$263K	﹤0.01%	1553
2020 Q4	–	Sell	-14,571	Closed	-$798K	–	1977
2020 Q3	$798K	Buy	14,571 +3,910	+37%	+$211K	0.02%	766
2020 Q2	$614K	Buy	+10,661	New	+$580K	0.02%	739

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schonfeld Strategic Advisors's CCXI Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 376,583 shares — an estimated $19.5M sold.

Schonfeld Strategic Advisors first reported a position in CCXI in Q2 2020 and held it in 5 quarters. The position peaked at $19.5M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Schonfeld Strategic Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 376,583 ChemoCentryx, Inc. shares in Q4 2022, an estimated $19.5M.
Schonfeld Strategic Advisors first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 5 quarters.
Schonfeld Strategic Advisors's ChemoCentryx, Inc. position peaked at $19.5M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.